Chinese stem cell therapy reverses heart failure in 90% of patients, landmark trial finds - Patients who received treatment ...

A HEAL-CHF trial found 90% of heart failure patients showed improved cardiac function after receiving lab-grown heart muscle cell injections.

When approved, they will be the world’s first practical medicines containing iPS cells, which can be re-engineered into other ...

A cell therapy made from donor heart cells slowed the decline of cardiac function in boys and young men with Duchenne ...

Heart muscle cells grown from patient stem cells—known as human induced pluripotent stem cell–derived cardiomyocytes, or hiPSC-CMs—are a promising way to repair hearts damaged by heart attacks and ...

A sweeping single-nucleus atlas reveals how human hearts lose cellular balance with age and points to PRDM16 as a potential molecular target for future cardiac aging research. Study: ...

The development of novel therapeutics offers great hope for the fight against widespread diseases such as cancer, but they can impair the cardiovascular system, so development often fails early on.

Duchenne muscular dystrophy (DMD) is a severe genetic neuromuscular disease caused by the absence of functional dystrophin, a large structural protein encoded by the X-chromosomal DMD gene. It is ...

A hospital in east China has used reprogrammed stem cells to treat severe heart failure, with 90 per cent of patients showing significant recovery in heart function after the novel therapy. On ...